Oncology Cash from 2010 to 2026

TOIIW Stock

USD 0.10 0.02 16.67%

Oncology Institute Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 40.3 M in 2026. Cash is the total amount of money in the form of currency that The Oncology Institute has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals

Cash

First Reported

2020-03-31

Previous Quarter

30.3 M

Current Value

27.7 M

Quarterly Volatility

28.6 M

Covid

Interest Hikes

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 4.3 M or Interest Expense of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.0644, Dividend Yield of 0.0105 or PTB Ratio of 9.87. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.

Build AI portfolio with Oncology Stock

Check out the analysis of Oncology Institute Correlation against competitors.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

The evolution of Cash for The Oncology Institute provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Oncology Institute compares to historical norms and industry peers.

Latest Oncology Institute's Cash Growth Pattern

Below is the plot of the Cash of The Oncology Institute over the last few years. Cash refers to the most liquid asset of The Oncology Institute, which is listed under current asset account on The Oncology Institute balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Oncology Institute customers. The amounts must be unrestricted with restricted cash listed in a different Oncology Institute account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Oncology Institute's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.

Cash

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Cash

Timeline

Oncology Cash Regression Statistics

	Arithmetic Mean	19,962,484
	Geometric Mean	7,080,084
	Coefficient Of Variation	153.68
	Mean Deviation	22,950,565
	Median	2,446,201
	Standard Deviation	30,678,137
	Sample Variance	941.1T
	Range	111.9M
	R-Value	0.61
	Mean Square Error	629.8T
	R-Squared	0.37
	Significance	0.01
	Slope	3,708,677
	Total Sum of Squares	15058.4T

Oncology Cash History

	2026	40.3 M
	2025	57.1 M
	2024	49.7 M
	2023	33.5 M
	2022	14 M
	2021	114.3 M
	2020	6 M

Other Fundumenentals of The Oncology Institute

	Cash And Short Term Investments
	Change In Cash
	Free Cash Flow
	Begin Period Cash Flow

Oncology Institute Cash component correlations

	Change In Cash	Free Cash Flow	Begin Period Cash Flow	End Period Cash Flow	Free Cash Flow Yield	Free Cash Flow Per Share	Cash Per Share	Ev To Free Cash Flow	Cash Ratio	Cash Conversion Cycle	Price Cash Flow Ratio	Cash Flow To Debt Ratio
Change In Cash		0.12	-0.59	0.66	0.01	0.08	0.35	-0.07	0.71	-0.53	-0.05	-0.71
Free Cash Flow	0.12		-0.84	-0.62	0.59	1.0	-0.87	0.29	-0.52	-0.82	0.3	0.29
Begin Period Cash Flow	-0.59	-0.84		0.22	-0.54	-0.82	0.5	-0.19	0.1	0.83	-0.23	0.07
End Period Cash Flow	0.66	-0.62	0.22		-0.47	-0.66	0.88	-0.25	0.95	0.13	-0.26	-0.8
Free Cash Flow Yield	0.01	0.59	-0.54	-0.47		0.63	-0.39	0.2	-0.2	-0.35	0.28	-0.11
Free Cash Flow Per Share	0.08	1.0	-0.82	-0.66	0.63		-0.87	0.3	-0.55	-0.78	0.3	0.31
Cash Per Share	0.35	-0.87	0.5	0.88	-0.39	-0.87		-0.26	0.86	0.53	-0.31	-0.69
Ev To Free Cash Flow	-0.07	0.29	-0.19	-0.25	0.2	0.3	-0.26		-0.18	-0.03	-0.8	0.1
Cash Ratio	0.71	-0.52	0.1	0.95	-0.2	-0.55	0.86	-0.18		0.04	-0.24	-0.94
Cash Conversion Cycle	-0.53	-0.82	0.83	0.13	-0.35	-0.78	0.53	-0.03	0.04		-0.36	0.15
Price Cash Flow Ratio	-0.05	0.3	-0.23	-0.26	0.28	0.3	-0.31	-0.8	-0.24	-0.36		0.14
Cash Flow To Debt Ratio	-0.71	0.29	0.07	-0.8	-0.11	0.31	-0.69	0.1	-0.94	0.15	0.14

Click cells to compare fundamentals

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Cash	57.1 M	40.3 M
Cash And Short Term Investments	57.1 M	60.3 M
Change In Cash	14.6 M	15.3 M
Free Cash Flow	-27.3 M	-28.7 M
Begin Period Cash Flow	38.5 M	26.9 M
Total Cashflows From Investing Activities	53.1 M	55.8 M
Other Cashflows From Financing Activities	-3.2 M	-3 M
Other Non Cash Items	1.9 M	2 M
Total Cash From Operating Activities	-23.9 M	-25.1 M
Total Cash From Financing Activities	-4 M	-3.8 M
End Period Cash Flow	57.1 M	34.7 M
Other Cashflows From Investing Activities	-113.5 M	-107.8 M
Free Cash Flow Yield	(1.50)	(1.43)
Operating Cash Flow Per Share	(0.41)	(0.43)
Free Cash Flow Per Share	(0.46)	(0.49)
Cash Per Share	0.60	0.62
Capex To Operating Cash Flow	(0.14)	(0.16)
EV To Operating Cash Flow	(4.19)	(3.98)
EV To Free Cash Flow	(2.87)	(3.01)
Price To Operating Cash Flows Ratio	(1.00)	(0.95)
Price To Free Cash Flows Ratio	(0.69)	(0.72)
Cash Ratio	0.86	0.88
Cash Conversion Cycle	26.82	24.87
Operating Cash Flow Sales Ratio	(0.08)	(0.08)
Free Cash Flow Operating Cash Flow Ratio	1.03	0.53
Cash Flow Coverage Ratios	(0.19)	(0.20)
Price Cash Flow Ratio	(1.00)	(0.95)
Cash Flow To Debt Ratio	(0.19)	(0.20)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Oncology Cash from 2010 to 2026

Latest Oncology Institute's Cash Growth Pattern

Oncology Cash Regression Statistics

Oncology Cash History

Other Fundumenentals of The Oncology Institute

Oncology Institute Cash component correlations

About Oncology Institute Financial Statements

Also Currently Popular

Additional Tools for Oncology Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY